10.9K(top 3%)
articles
406K(top 2%)
citations
2,846(top 3%)
★★ articles
137(top 2%)
★★★ articles
3(top 13%)
Avg IF
226(top 2%)
H-Index
407(top 2%)
G-Index
2,316
journals

Most Cited Articles of Jewish General Hospital in 2018

TitleJournalYearCitations
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA StatementJAMA - Journal of the American Medical Association20181K
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and ChildrenCanadian Journal of Cardiology2018348
High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and BodiesMolecular Cell2018331
Genetic architecture: the shape of the genetic contribution to human traits and diseaseNature Reviews Genetics2018219
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Annals of the Rheumatic Diseases2018172
The vaccine hesitancy scale: Psychometric properties and validationVaccine2018142
Signaling Pathways Involved in the Regulation of mRNA TranslationMolecular and Cellular Biology2018138
Neurofeedback with fMRI: A critical systematic reviewNeuroImage2018136
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)Proceedings of the National Academy of Sciences of the United States of America2018128
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific EffectsAmerican Journal of Human Genetics2018119
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse modelNature Communications2018117
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation studyBMJ, The2018114
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers WorkgroupGeroScience2018111
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.Journal of Clinical Oncology2018100
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort studyBMJ, The201894
SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trialsActa Diabetologica201891
Cardiovascular disease and COPD: dangerous liaisons?European Respiratory Review201887
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancerNature Communications201881
Epidemiology of pain and relation to psychiatric disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry201880
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?Diabetes Care201878
477. Trends in the Incidence of Community-Associated and Healthcare-Associated Clostridium difficile Infections in Quebec Over a 7-Year Period (2008–2015)Open Forum Infectious Diseases201878
243. Prioritization of Antibiotic Administration for STAT Orders in the Septic Patient: A Retrospective AnalysisOpen Forum Infectious Diseases201878
UTILITY OF A GENERAL PROGNOSTIC SCORE IN IDENTIFYING PATIENTS WITH POOR OUTCOMES AFTER AORTIC VALVE REPLACEMENTInnovation in Aging201878
DIPG-06. IDENTIFICATION OF GENES FUNCTIONALLY INVOLVED IN THE DETRIMENTAL EFFECTS OF MUTANT HISTONE K27M-H3.3 USING DROSOPHILA MELANOGASTERNeuro-Oncology201878
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulationNature Communications201875